Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in the management of renal cell carcinoma.
Cardenas LM, Sigurdson S, Wallis CJD, Lalani AK, Swaminath A. Cardenas LM, et al. Among authors: lalani ak. CMAJ. 2024 Feb 25;196(7):E235-E240. doi: 10.1503/cmaj.230356. CMAJ. 2024. PMID: 38408783 Free PMC article. Review. No abstract available.
The emerging treatment landscape of advanced urothelial carcinoma.
Cardenas L, Dibajnia P, Lalani AK. Cardenas L, et al. Among authors: lalani ak. Curr Opin Support Palliat Care. 2021 Dec 1;15(4):247-252. doi: 10.1097/SPC.0000000000000573. Curr Opin Support Palliat Care. 2021. PMID: 34620772 Review.
Emerging Biomarker-Guided Therapies in Prostate Cancer.
Deluce JE, Cardenas L, Lalani AK, Maleki Vareki S, Fernandes R. Deluce JE, et al. Among authors: lalani ak. Curr Oncol. 2022 Jul 18;29(7):5054-5076. doi: 10.3390/curroncol29070400. Curr Oncol. 2022. PMID: 35877260 Free PMC article. Review.
Percées dans la prise en charge de l’hypernéphrome.
Cardenas LM, Sigurdson S, Wallis CJD, Lalani AK, Swaminath A. Cardenas LM, et al. Among authors: lalani ak. CMAJ. 2024 May 5;196(17):E601-E607. doi: 10.1503/cmaj.230356-f. CMAJ. 2024. PMID: 38719217 Free PMC article. Review. French. No abstract available.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population.
Millan B, Breau RH, Mallick R, Wood L, Rendon R, Finelli A, So AI, Lavallée LT, Pouliot F, Bhindi B, Heng D, Drachenberg D, Tanguay S, Dean L, Basappa NS, Lattouf JB, Bjarnason G, Lalani AK, Kapoor A. Millan B, et al. Among authors: lalani ak. Urol Oncol. 2023 Jul;41(7):328.e15-328.e23. doi: 10.1016/j.urolonc.2023.04.015. Epub 2023 May 16. Urol Oncol. 2023. PMID: 37202328
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Sawaya GB, Dragomir A, Wood LA, Kollmannsberger C, Basappa NS, Kapoor A, Soulières D, Finelli A, Heng DYC, Castonguay V, Canil C, Winquist E, Graham J, Bjarnason GA, Bhindi B, Lalani AK, Pouliot F, Breau RH, Saleh R, Tanguay S. Sawaya GB, et al. Among authors: lalani ak. Eur Urol Oncol. 2024 Jun;7(3):570-580. doi: 10.1016/j.euo.2023.11.016. Epub 2023 Dec 13. Eur Urol Oncol. 2024. PMID: 38097481
71 results